KTS has been found to be correlated with mosaic-activating variants in the PIK3CA gene, and therefore the syndrome has been included in the group of PIK3CA-related overgrowth syndrome (PROS) phenotypes, with or without vascular anomalies [1]. Here, PIK3CA is linked to overgrowth syndrome.